Komori
Solasia Pharma K.K. (4597) · InitiativeAdvanced

Investment in HikariQ Health and Its Conversion into an Equity-Method Affiliate

First written in FY2022-Q2. 3 of 4 entries say "Advanced", first in FY2022. Latest entry: 2026-08-13.

4entries
5years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022-Q2AdvancedFY2022 – 2026-08-132022: 120222023: 120232024: 020242025: 020252026: 22026
Same theme, other companies
Investment in HikariQ Health and Collaboration on Next-Generation ADC Drug DiscoveryA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  2. FY2022AdvancedAnnual report

    「当社及びHikariQ Health社は、同社と共にQ-body技術を応用した 次世代ADC創薬の初期検討にも着手しております。」

    HikariQ Healthへの出資・持分法適用関連会社化に続き、Q-body技術を応用した次世代ADC創薬の初期検討に着手した。
  3. FY2022-Q2First statedAnnual report

    「During the second quarter accounting period, the Company invested in HikariQ Health Co., Ltd. and newly classified it as an equity-method associate.」

    The Company invested in HikariQ Health and made it a new equity-method associate.
Moved together

"SP-01: Sancuso® Approved and Launched in China" moved the same way as this thread, in the same document, in 2 of its 4 moves.

222222★123456
  1. ★This thread
  2. 1SP-01: Sancuso® Approved and Launched in China2×
  3. 2Combined Use of the China Direct-Sales Model and Derived Models for Other Regions2×
  4. 3Development and Commercialization of SP-04 PledOx in Japan and Asia2×
  5. 4Joint research on novel drug discovery in oncology using RNA editing technology2×
  6. 5Expanding SP-04 PledOx’s Indications to Paclitaxel and Other Treatments2×
  7. 6Joint commercialization study for functional fluorescent probes with Goryo Chemical2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Solasia Pharma K.K. yet. It last moved in the Earnings presentation of 2026-08-13: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Investment in HikariQ Health and Its Conversion into an Equity-Method Affiliate | Solasia Pharma K.K. (4597) | Komori